Amneal Pharmaceuticals, Inc. AMRX Specialty — Regulatory fees

Similar metrics at other companies

SCHWRegulatory fees and assessments

$75M-15.7%

SCHWAdvisor Services — Regulatory fees and assessments

$16M-15.8%

CBOERegulatory fees — Total revenues

$10.4M-93.6%

CBOERegulatory fees cost of revenues — Total cost of revenues

$0-100%

ORISpecialty Insurance Group — Commissions, Insurance taxes, licenses, and fees

$191.6M+5.1%

SCHWInvestor Services — Regulatory fees and assessments

$59M-15.7%

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s specialty — regulatory fees?

Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — regulatory fees of $0 in Q1 2026.

What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — regulatory fees?

Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — regulatory fees has grown at a -100.0% compound annual growth rate (CAGR), from $3.12M to $0.

What does specialty — regulatory fees mean?

Includes payments made to government agencies or regulatory bodies for product approvals, compliance filings, and ongoing market authorization maintenance. These costs are essential for sustaining the segment's ability to market and sell pharmaceutical products.